Nursing Dilemmas in Chemotherapy-Induced Peripheral Neuropathy: A Qualitative Study of a Tertiary Hospital in China

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Livshits Z, Rao RB, Smith SW. An approach to chemotherapy-associated toxicity. Emerg Med Clin North Am. 2014;32(1):167–203. doi:10.1016/j.emc.2013.09.002
   PubMed Web of Science ®Google Scholar
• Avallone A, Bimonte S, Cardone C, Cascella M, Cuomo A. Pathophysiology and therapeutic perspectives for chemotherapy-induced peripheral neuropathy. Anticancer Res. 2022;42(10):4667–4678. doi:10.21873/anticanres.15971
   PubMed Web of Science ®Google Scholar
• Jahn F, Wörmann B, Brandt J, Freidank A, Feyer P, Jordan K. The prevention and treatment of nausea and vomiting during tumor therapy. Dtsch Arztebl Int. 2022;119(21):382–392. doi:10.3238/arztebl.m2022.0093
   PubMed Web of Science ®Google Scholar
• Epstein RS, Aapro MS, Basu Roy UK, et al. Patient burden and real-world management of chemotherapy-induced myelosuppression: results from an online survey of patients with solid tumors. Adv Ther. 2020;37(8):3606–3618. doi:10.1007/s12325-020-01419-6
   PubMed Web of Science ®Google Scholar
• Paus R, Haslam IS, Sharov AA, Botchkarev VA. Pathobiology of chemotherapy-induced hair loss. Lancet Oncol. 2013;14(2):e50–9. doi:10.1016/s1470-2045(12)70553-3
   PubMed Web of Science ®Google Scholar
• Bhatnagar B, Gilmore S, Goloubeva O, et al. Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience. Springerplus. 2014;3:366. doi:10.1186/2193-1801-3-366
   PubMedGoogle Scholar
• Miaskowski C, Mastick J, Paul SM, et al. Impact of chemotherapy-induced neurotoxicities on adult cancer survivors’ symptom burden and quality of life. J Cancer Surviv. 2018;12(2):234–245. doi:10.1007/s11764-017-0662-8
   PubMed Web of Science ®Google Scholar
• Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;22(8):2261–2269. doi:10.1007/s00520-014-2255-7
   PubMed Web of Science ®Google Scholar
• Banach M, Juranek JK, Zygulska AL. Chemotherapy-induced neuropathies-A growing problem for patients and health care providers. Brain Behav. 2017;7(1):e00558. doi:10.1002/brb3.558
   PubMed Web of Science ®Google Scholar
• Chan CW, Cheng H, Au SK, et al. Living with chemotherapy-induced peripheral neuropathy: uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors. Eur J Oncol Nurs. 2018;36:135–141. doi:10.1016/j.ejon.2018.09.003
   PubMed Web of Science ®Google Scholar
• Flatters SJL, Dougherty PM, Colvin LA. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. Br J Anaesth. 2017;119(4):737–749. doi:10.1093/bja/aex229
   PubMed Web of Science ®Google Scholar
• Alejandro LM, Behrendt CE, Chen K, Openshaw H, Shibata S. Predicting acute and persistent neuropathy associated with oxaliplatin. Am J Clin Oncol. 2013;36(4):331–337. doi:10.1097/COC.0b013e318246b50d
   PubMed Web of Science ®Google Scholar
• Jones SE, Erban J, Overmoyer B, et al. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol. 2005;23(24):5542–5551. doi:10.1200/jco.2005.02.027
   PubMed Web of Science ®Google Scholar
• Jordan B, Margulies A, Cardoso F, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31(10):1306–1319. doi:10.1016/j.annonc.2020.07.003
   PubMed Web of Science ®Google Scholar
• Kleckner IR, Kamen C, Gewandter JS, et al. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer. 2018;26(4):1019–1028. doi:10.1007/s00520-017-4013-0
   PubMed Web of Science ®Google Scholar
• Burgess J, Ferdousi M, Gosal D, et al. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment. Oncol Ther. 2021;9(2):385–450. doi:10.1007/s40487-021-00168-y
   PubMed Web of Science ®Google Scholar
• Dong ZB, Wang YJ, Cheng ML, et al. 2-Bromopalmitate decreases spinal inflammation and attenuates oxaliplatin-induced neuropathic pain via reducing Drp1-mediated mitochondrial dysfunction. PLoS One. 2022;17(10):e0275428. doi:10.1371/journal.pone.0275428
   PubMedGoogle Scholar
• Jia M, Wu C, Gao F, et al. Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain. Mol Pain. 2017;13:1744806917719804. doi:10.1177/1744806917719804
   Web of Science ®Google Scholar
• Kanzawa-Lee GA. Chemotherapy-induced peripheral neuropathy: nursing implications. J Infus Nurs. 2020;43(3):155–166. doi:10.1097/nan.0000000000000368
   PubMed Web of Science ®Google Scholar
• Wang Y, Fu JF, Bai YN, Xie J, Jiao HX, Wang ZL. Knowledge, attitude and practice regarding Chemotherapy-Induced Peripheral Neuropathy assessment and management among oncology nurses. Chin Nurs Manage. 2018;18(03):382–387. doi:10.3969/j.issn.1672-1756.2018.03.021
   Google Scholar
• Binner M, Ross D, Browner I. Chemotherapy-induced peripheral neuropathy: assessment of oncology nurses’ knowledge and practice. Article. Oncol Nurs Forum. 2011;38(4):448–454. doi:10.1188/11.ONF.448-454
   PubMed Web of Science ®Google Scholar
• Al-Atiyyat NM, Banifawaz AZ. Oncology nurses’ knowledge, practice, and confidence toward chemotherapy-induced peripheral neuropathy in Jordan. Saudi Med J. 2018;39(11):1158–1163. doi:10.15537/smj.2018.11.23303
   PubMed Web of Science ®Google Scholar
• Yang Y, Dong YG, Gu LL, et al. Construction of an evaluation index system for the core competence of chemotherapy specialist nurses. Chin J Nurs. 2017;52(10):1226–1231. doi:10.3761/j.issn.0254-1769.2017.10.015
   Google Scholar
• Guo LX. Development and Application of Shared Decision Making Questionnaire Among Oncology Nurses Based on the Theory of Knowledge-Attitude-Practice. Master. Zhengzhou University; 2021.
   Google Scholar
• Colvin LA. Chemotherapy-induced peripheral neuropathy: where are we now? Pain. 2019;160(Suppl 1):S1–s10. doi:10.1097/j.pain.0000000000001540
   PubMed Web of Science ®Google Scholar
• Seretny M, Currie G, Sena E, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461–2470. doi:10.1016/j.pain.2014.09.020
   PubMed Web of Science ®Google Scholar
• Meng AF. Jiangsu Province Adult cancer pain Care Standard (2020 version). Med High Vocation Educ Mod Nurs. 2020;3(4):229–244. doi:10.3969/j.issn.2096-501X.2020.04.001
   Google Scholar
• Bie MJ, Hu JE, Xiang YH, Chen HY. Evidences for the evaluation and management of chemotherapy-induced peripheral neuropathy. Chin Clin Nurs. 2021;13(09):552–557. doi:10.3969/j.issn.1674-3768.2021.09.006
   Google Scholar
• Bie MJ, Xiang YH, Zhang GP, Hu JE, Chen HY. Formulation of an evidence-based nursing program for chemotherapy-induced peripheral neurotoxicity based on best evidences. Mod Clin Nurs. 2021;20(08):63–72. doi:10.3969/j.issn.1671-8283.2021.08.010
   Google Scholar
• Conley C, Kamen CS, Heckler CE, et al. Modafinil moderates the relationship between cancer-related fatigue and depression in 541 patients receiving chemotherapy. J Clin Psychopharmacol. 2016;36(1):82–85. doi:10.1097/JCP.0000000000000442
   PubMed Web of Science ®Google Scholar
• Morrison EJ, Novotny PJ, Sloan JA, et al. Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin Lung Cancer. 2017;18(5):497–503. doi:10.1016/j.cllc.2017.02.008
   PubMed Web of Science ®Google Scholar
• Rochmawati E, Minanton M. Embedded spiritual conversation in cancer communication: lived experiences of nurses and patients/relatives. Int Nurs Rev. 2021;68(3):289–298. doi:10.1111/inr.12634
   PubMed Web of Science ®Google Scholar
• Connolly M, Perryman J, McKenna Y, et al. SAGE & THYME: a model for training health and social care professionals in patient-focussed support. Patient Educ Couns. 2010;79(1):87–93. doi:10.1016/j.pec.2009.06.004
   PubMed Web of Science ®Google Scholar
• Gao XY. Construction and Effects Evaluation of Goals-of-Care Communication Mode for Advanced Cancer Patients. Master. Zhengzhou University; 2021.
   Google Scholar
• Tang LY, Zhang W. Exploring the nurse-patient community from the perspective of the relationship between symptom of lung cancer patients undergoing chemotherapy and narses’negative emotions. J Nurs Sci. 2020;35(22):57–59. doi:10.3870/j.issn.1001-4152.2020.22.057
   Google Scholar